Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Intravenous Solutions Market Set To Climb From $16.05 Billion In 2026 To $21.73 Billion By 2030
The intravenous solutions market has witnessed significant expansion in recent years. Its valuation is anticipated to increase from $14.91 billion in 2025 to $16.05 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.6%. Historically, this market’s growth has been driven by factors such as a rise in hospital admissions and surgical interventions, the extensive application of IV fluids for dehydration management, an escalating incidence of chronic illnesses, the established significance of IV therapy in critical care settings, and the growing demand for electrolyte and glucose solutions.
The intravenous solutions market is projected to experience substantial expansion over the coming years, reaching $21.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. This anticipated growth during the forecast period is driven by several factors, including the increasing availability of home healthcare and outpatient infusion services, a growing elderly population in need of nutritional assistance, the increasing uptake of customized nutrition treatments, innovations in sterile packaging, and the rising need for extended parenteral nutrition. Key trends anticipated for this period encompass a heightened demand for intravenous hydration in both acute and chronic care settings, broader application of parenteral nutrition in critical and elderly patient care, a stronger inclination towards ready-to-use IV solution formulas, the proliferation of home-based IV therapy and infusion services, and an intensified emphasis on maintaining sterility and safety during IV solution production.
Get A Free Sample Report With In-Depth Market Insights:
Intravenous Solutions Market Growth Factors: What’s Supporting Expansion?
The expanding occurrence of cancer is projected to fuel the future expansion of the intravenous solutions market. This condition encompasses various illnesses marked by unchecked cell multiplication, capable of infiltrating adjacent tissues and disseminating throughout the body. Intravenous solutions are frequently employed in oncology care for administering chemotherapy agents and ensuring patient hydration during treatment. For example, data from February 2024 by the World Health Organization, a Switzerland-based intergovernmental body, forecast more than 35 million new cancer diagnoses by 2050, showing a 77% rise from the approximately 20 million cases estimated in 2022. Consequently, the rising incidence of cancer is a key factor propelling the growth of the intravenous solutions market.
Intravenous Solutions Market Segment Analysis Spotlighting Growth Areas
The intravenous solutions market covered in this report is segmented –
1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition
2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients
3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution
4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings
Subsegments:
1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions
2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions
Intravenous Solutions Market Industry Trends: What’s Reshaping Demand?
Leading companies in the intravenous solutions market are concentrating on developing innovative syringes, such as pre-filled and ready-to-administer types, to gain a competitive edge. These pre-filled and ready-to-administer syringes are preloaded with medication and designed for immediate use without requiring manual filling or preparation. For instance, in August 2023, GENIXUS Corp., a US-based healthcare company, launched KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. These syringes are constructed from a transparent, durable polymer material, thereby eliminating the risks associated with glass syringes. Their pre-filled and ready-to-administer nature saves time and helps reduce medication errors. Rocuronium bromide injection is solely for intravenous use. It boasts several crucial attributes, including being RFID-enabled with KitCheck, which is the latest kit and tray management technology, alongside intuitive labeling and a color-coded plunger rod to support rapid identification.
Intravenous Solutions Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the intravenous solutions market are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.
View The Full Intravenous Solutions Market Report:
Intravenous Solutions Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the intravenous solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
